Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disorder in which the immune system mistakenly attacks the synovium — the thin membrane that lines and lubricates the joints. This triggers ongoing inflammation that thickens the synovium, damages cartilage and bone within the joint, and, left unchecked, can lead to permanent joint deformity and disability. Unlike osteoarthritis, which results from mechanical wear and tear on joints over time, rheumatoid arthritis is driven by the body's own immune system attacking healthy joint tissue — a fundamental difference that shapes how it is diagnosed, monitored and treated.

RA typically affects joints symmetrically — meaning if one wrist is affected, the other usually is too — and most commonly involves the small joints of the hands, wrists and feet, though it can affect almost any joint in the body. It affects roughly 0.5 to 1% of adults worldwide, is two to three times more common in women, and most often begins between the ages of 30 and 60, although it can develop at any age, including in children (a related but distinct condition called juvenile idiopathic arthritis).

The way rheumatoid arthritis is understood and treated has changed substantially over the past two decades. It is no longer viewed simply as a joint disease to be managed with painkillers, but as a systemic inflammatory condition that, without effective treatment, can affect the lungs, heart, blood vessels and other organs — and one where early, aggressive treatment aimed at a specific target (rather than simply easing symptoms) can prevent much of the joint damage that used to be considered inevitable.

What Actually Happens Inside an Affected Joint

In a healthy joint, the synovium is a thin, smooth membrane that produces a small amount of fluid to lubricate movement. In rheumatoid arthritis, immune cells — including T cells, B cells and inflammatory proteins called cytokines (particularly TNF-alpha, interleukin-6 and interleukin-1) — infiltrate the synovium, causing it to thicken and become inflamed. This thickened, inflamed tissue is called pannus, and it behaves almost like an abnormal growth: it invades and erodes the adjacent cartilage and bone, releasing enzymes that break down joint structures over time.

This is why early, effective treatment matters so much. Cartilage, once destroyed, does not regenerate, and bone erosion visible on X-ray is generally permanent. The inflammatory process can be substantially and often completely controlled with modern treatment, but structural damage that has already occurred generally cannot be reversed — a central reason why rheumatologists now emphasise early diagnosis and prompt treatment within what is sometimes called the "window of opportunity," the period early in the disease when treatment appears most able to prevent long-term joint damage and, in some patients, achieve drug-free remission.

Seropositive vs Seronegative RA

Not all rheumatoid arthritis looks the same on blood testing, and this distinction has real clinical relevance for diagnosis, expected disease course and, to some extent, treatment choice.

• Seropositive RA: Around 70 to 80% of people with RA test positive for rheumatoid factor (RF) and/or anti-citrullinated protein antibodies (anti-CCP or ACPA) — antibodies that mistakenly target the body's own tissues. Seropositive RA, particularly when anti-CCP is strongly positive, is generally associated with a higher likelihood of joint erosion and more aggressive disease if untreated, and anti-CCP antibodies can be detectable in the blood years before symptoms even begin.
• Seronegative RA: Around 20 to 30% of people with clinically typical RA test negative for both RF and anti-CCP. Seronegative RA is diagnosed based on clinical features, examination findings and imaging rather than blood antibody results, and while it can be just as active and damaging as seropositive disease, it is sometimes more challenging to diagnose definitively and may occasionally represent a different, related inflammatory arthritis rather than classic RA.

Importantly, a negative RF or anti-CCP test does not rule out RA, and treatment decisions are based primarily on clinical disease activity, not antibody status alone.

What causes Rheumatoid Arthritis?

The exact trigger for RA is not fully understood, but it is thought to arise when a genetically susceptible person is exposed to an environmental trigger that sets off an abnormal, self-sustaining immune response.

• Genetic susceptibility: Certain genes, particularly variations in the HLA-DRB1 gene (part of the "shared epitope"), are associated with a higher risk of developing RA and, in some studies, with more severe disease. Genetics alone does not cause RA — most people with these gene variants never develop the condition.
• Smoking: Smoking is the most well-established environmental risk factor, particularly in genetically susceptible individuals, and is thought to trigger citrullination — a chemical change in proteins that can make them targets for the immune system's anti-CCP antibodies.
• Chronic periodontal (gum) disease: Gum disease caused by certain bacteria has been linked to the same citrullination process implicated in smoking, and periodontal disease is more common in people with RA.
• Gut microbiome changes: Emerging research suggests that the composition of gut bacteria may influence immune regulation and could play a role in triggering or sustaining autoimmune inflammation in susceptible individuals, an active area of ongoing study.
• Hormonal factors: RA is roughly two to three times more common in women, and hormonal factors are thought to play a role, although the precise mechanism is not fully understood; RA can also improve during pregnancy and flare afterward in some women.

Symptoms of Rheumatoid Arthritis

RA typically develops gradually over weeks to months, though it can occasionally begin more abruptly. Symptoms tend to fluctuate, with periods of worse disease activity (flares) interspersed with periods of relatively lower activity.

Joint Symptoms

• Pain, swelling, warmth and tenderness in affected joints, typically starting in the small joints of the hands, wrists and feet
• Symmetrical joint involvement — the same joints affected on both sides of the body — a hallmark feature that helps distinguish RA from many other forms of arthritis
• Morning stiffness lasting more than 30 to 60 minutes, and stiffness after any period of inactivity, that gradually eases with movement
• Joint involvement that spreads to additional joints over time if untreated
• Reduced grip strength and difficulty with fine motor tasks as hand joints are affected

Whole-Body (Systemic) Symptoms

• Persistent fatigue, which can be profound and is one of the most commonly reported and disabling symptoms of RA, sometimes appearing even before joint symptoms are prominent
• Low-grade fever
• Loss of appetite and unintended weight loss
• A general feeling of being unwell (malaise)

It is worth noting that RA does not only affect joints — the systemic, whole-body inflammation it causes is now recognised as central to the condition, which is part of why untreated RA is linked to health risks well beyond the joints themselves, discussed further below.

Risk Factors for Rheumatoid Arthritis

• Age: Although RA can develop at any age, it most commonly begins between the ages of 30 and 60, with incidence continuing to rise into older adulthood.
• Sex: Women are two to three times more likely than men to develop RA.
• Family history: Having a first-degree relative with RA increases personal risk, reflecting a genetic contribution to susceptibility.
• Smoking: Current and past smokers face a higher risk of developing RA, tend to develop more severe disease, and may respond less well to certain treatments if they continue smoking.
• Obesity: Excess weight is linked to a higher risk of developing RA and can make the disease harder to bring into remission.
• Specific genetic variants: Certain HLA-DRB1 gene variants (the "shared epitope") are associated with increased susceptibility, particularly in combination with smoking.

Complications and Associated Conditions of Rheumatoid Arthritis

Because RA reflects ongoing, system-wide inflammation rather than a problem confined to the joints, uncontrolled disease is linked to a wide range of complications affecting other organs — a key reason modern RA care extends well beyond pain relief.

• Cardiovascular disease: Chronic inflammation increases the risk of atherosclerosis (hardening and narrowing of the arteries), and people with RA face a meaningfully higher risk of heart attack and stroke than the general population — a risk now considered comparable in some studies to that conferred by diabetes, and one that is independent of traditional risk factors such as cholesterol.
• Lung disease: RA can cause inflammation and scarring of lung tissue (interstitial lung disease), as well as inflammation of the lining around the lungs (pleuritis) — RA-associated lung disease is an important cause of illness and, in some cases, mortality in people with RA, and is increasingly screened for in those with risk factors or respiratory symptoms.
• Anaemia: Chronic inflammation can suppress red blood cell production, leading to anaemia of chronic disease, which contributes to the fatigue many people with RA experience.
• Rheumatoid nodules: Firm lumps of tissue that form under the skin, usually around pressure points such as the elbows, fingers and heels, seen mainly in longstanding seropositive RA.
• Dry eyes and mouth (secondary Sjögren's syndrome): Reduced saliva and tear production, sometimes overlapping with a related autoimmune condition called Sjögren's syndrome, causing dry eyes, dry mouth and increased dental and eye complications.
• Osteoporosis: Both the chronic inflammation of RA and long-term glucocorticoid (steroid) use increase the risk of osteoporosis and fragility fractures, making bone density monitoring an important part of long-term care.
• Vasculitis: Chronic inflammation can affect the small blood vessels (vasculitis) in more severe, longstanding disease, and, less commonly, larger vessels — a serious complication requiring prompt treatment.
• Cervical spine involvement: RA-related inflammation of the joints and ligaments in the neck (cervical spine), particularly the upper cervical spine, can occasionally cause instability requiring specific monitoring, especially before procedures involving neck movement such as general anaesthesia.
• Increased infection risk: Both RA itself and some of its treatments can modestly affect immune function, increasing susceptibility to infection — a factor carefully weighed and monitored throughout treatment.
• Mental health impact: The unpredictability, chronic pain and functional impact of RA are associated with meaningfully higher rates of depression and anxiety, which are now recognised as an important part of comprehensive RA care.

How Rheumatoid Arthritis Is Diagnosed

There is no single definitive test for RA. Diagnosis combines clinical assessment, blood tests and imaging, guided by internationally recognised classification criteria (the ACR/EULAR criteria), which score factors such as the number and type of joints involved, blood test results, inflammatory markers and symptom duration.

• Clinical History & Joint Examination: A detailed history of joint symptoms, their pattern and duration, morning stiffness, and systemic symptoms, together with a physical examination to identify which and how many joints are swollen or tender.
• Rheumatoid Factor (RF): An antibody detectable in the blood of most, but not all, people with RA; also present in some other conditions and in a small proportion of healthy people, so it is interpreted alongside clinical findings.
• Anti-CCP (Anti-Citrullinated Protein Antibody): A more specific antibody test for RA than RF, often positive years before symptoms begin, and associated with a higher likelihood of joint erosion; a strongly positive result supports both diagnosis and a more proactive treatment approach.
• Inflammatory Markers (ESR and CRP): Blood tests measuring general inflammation levels in the body, used both to support diagnosis and, importantly, to help track disease activity and response to treatment over time.
• Full Blood Count & Other Blood Tests: Checks for anaemia of chronic disease and establishes baseline organ function (kidney and liver) before starting certain medications.
• X-Ray: Used to check for joint erosion and damage, which may be absent early in the disease but becomes an important marker of accumulated joint damage in established or inadequately treated RA.
• Ultrasound or MRI: More sensitive than X-ray for detecting active joint inflammation (synovitis) and very early erosions, increasingly used to support diagnosis and guide treatment decisions before changes are visible on X-ray.

Living Well With RA: Practical Self-Management

• Stay physically active: Low-impact aerobic exercise, strength training and range-of-motion exercises help maintain joint function and muscle support around affected joints, and are safe and beneficial even during periods of active disease when guided appropriately.
• Quit smoking: Quitting smoking is one of the most impactful things a person with RA can do — it is linked to more severe disease, reduced treatment response, and added cardiovascular risk on top of that already conferred by RA.
• Manage cardiovascular risk factors: Given the significantly elevated cardiovascular risk associated with RA, managing blood pressure, cholesterol and weight, and staying physically active, are important parts of long-term care, not a separate concern from joint health.
• Use heat, cold and pacing strategically: Applying heat to ease stiffness, cold to reduce swelling during flares, and pacing activities to balance rest and activity can help manage day-to-day symptoms.
• Support your diet and weight: A balanced, anti-inflammatory-leaning diet (such as a Mediterranean-style diet) and maintaining a healthy weight can support overall health and may modestly help manage inflammation, alongside — not instead of — medical treatment.
• Look after your mental health: Chronic pain, fatigue and unpredictability take a real emotional toll; connecting with a counsellor, support group or occupational therapist for coping strategies is a valid and valuable part of comprehensive care.
• Keep up with regular rheumatology follow-up: RA is most effectively managed with regular monitoring and prompt adjustment of treatment when disease activity is not adequately controlled — staying engaged with scheduled reviews, even when feeling well, supports the treat-to-target approach that drives better long-term outcomes.